Results 131 to 140 of about 9,581 (161)

Montelukast: Hepatotoxicity (First Report*)

Clin-Alert, 2003
openaire   +1 more source

Montelukast in hospitalized patients diagnosed with COVID-19

Journal of Asthma, 2022
Navaneeth Narayanan, Jared Radbel, Nikhil Yegya-Raman   +2 more
exaly  

Montelukast and Acute Coronary Syndrome: The Endowed Drug

Pharmaceuticals, 2022
Ali I Al-Gareeb, Hebatallah M Saad, Michel De Waard   +2 more
exaly  

Risk of Psychiatric Adverse Events Among Montelukast Users

Journal of Allergy and Clinical Immunology: in Practice, 2021
Efe Eworuke, Sengwee Toh
exaly  

Montelukast

Inpharma Weekly, 1999
openaire   +1 more source

Short-Course Montelukast for Intermittent Asthma in Children

American Journal of Respiratory and Critical Care Medicine, 2007
Dominic Fitzgerald, Nicholas Glasgow
exaly  

Influence of Leukotriene Pathway Polymorphisms on Response to Montelukast in Asthma

American Journal of Respiratory and Critical Care Medicine, 2006
Hooman Allayee, Robert Wise, John J Lima   +2 more
exaly  

CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast

British Journal of Clinical Pharmacology, 2012
Janne Tapio Backman, Pertti Jaakko Neuvonen   +1 more
exaly  

Montelukast

Reactions Weekly, 2013
openaire   +1 more source

Effect of montelukast in experimental model of Parkinson’s disease

Neuroscience Letters, 2018
Vetrivel Babu
exaly